Research Article
Loss of RASSF1A Expression in Colorectal Cancer and Its Association with K-ras Status
Table 2
Association between loss of RASSF1A expression and clinicopathological factors.
| Factors | Total cases | Loss of RASSF1A expression | No. | No. (% of total) | | P |
| Age | | | | | <60 | 41 | 22 (53.66%) | 0.196 | 0.658 | ≥60 | 35 | 17 (48.57%) | | | Sex | | | | | Male | 44 | 27 (61.36%) | 4.223 | 0.040 | Female | 32 | 12 (37.5%) | | | Site | | | | | Colon | 38 | 24 (63.16%) | 4.266 | 0.039 | Rectum | 38 | 15 (39.47%) | | | Tumor size | | | | | <5 cm | 55 | 31 (56.36%) | 2.030 | 0.154 | ≥5 cm | 21 | 8 (38.10%) | | | Differentiation grade | | | | | Poor | 32 | 13 (40.63%) | 2.529 | 0.112 | Moderate-well | 44 | 26 (59.09%) | | | Invasion depth | | | | | T1 + T2 | 17 | 11 (64.71%) | 1.572 | 0.210 | T3 + T4 | 59 | 28 (47.58%) | | | Tumor stage | | | | | I/II/III | 56 | 28 (50%) | 0.114 | 0.736 | IV | 20 | 11 (55%) | | |
|
|
Bold values represent values which are considered to be statistically significant at 0.05.
|